News
Pfizer is undervalued as markets fixate on its patent cliff, overlooking strong cash flows, pipeline upside, and a 7% yield.
Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...
3d
24/7 Wall St. on MSNIs It Time to Invest in Pfizer? Exploring its 7% Dividend Yield and Growth PotentialPfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...
For this list, we're looking at U.S. stocks only that trade on major exchanges, with market caps of at least $10 billion. The ...
My final reason for buying more Pfizer stock is that I'll get paid nicely to wait and see if the drugmaker lives up to Wall Street's growth outlook. Pfizer's forward dividend yield currently stands at ...
2d
Zacks Investment Research on MSNPfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast of a dominant position in the lucrative oncology space. Oncology ...
Real-time index price for KBW Finsec Dividend Yield Index (KDX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Ritholtz Wealth Management ramped up its Pfizer position by 54.7% in Q1, snagging 18,309 new shares like it’s scooping Black ...
Dan Meers, who was the first mascot for the Kansas City Chiefs, has announced his retirement after 35 years of faithful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results